Table 1.
Index | Group | 0 weeks | 4 weeks | 8 weeks | 12 weeks | 16 weeks | 20 weeks |
---|---|---|---|---|---|---|---|
TV (mL) | Control | 2.86 ± 0.46 | 2.88 ± 0.33 | 2.89 ± 0.34 | 2.90 ± 0.32 | 2.91 ± 0.36 | 2.92 ± 0.24 |
COPD | 2.90 ± 0.38 | 2.49 ± 0.24 | 2.06 ± 0.22 | 1.93 ± 0.22 | 1.92 ± 0.30 | 1.89 ± 0.36 | |
BYF | 2.97 ± 0.46 | 2.52 ± 0.21 | 2.04 ± 0.33 | 2.11 ± 0.18 | 2.14 ± 0.25 | 2.22 ± 0.36 | |
| |||||||
PEF (mL/s) | Control | 14.43 ± 2.69 | 14.72 ± 2.48 | 15.16 ± 1.99 | 15.25 ± 2.02 | 15.31 ± 1.75 | 15.30 ± 2.24 |
COPD | 14.11 ± 2.47 | 11.28 ± 2.00 | 9.99 ± 2.33 | 9.90 ± 1.96 | 9.93 ± 2.40 | 10.02 ± 2.18 | |
BYF | 14.49 ± 2.53 | 11.78 ± 1.96 | 10.03 ± 2.48 | 11.15 ± 2.51 | 11.81 ± 2.61 | 12.35 ± 2.84 | |
| |||||||
EF50 (mL/s) | Control | 1.72 ± 0.16 | 1.76 ± 0.12 | 1.75 ± 0.15 | 1.81 ± 0.17 | 1.93 ± 0.28 | 1.97 ± 0.21 |
COPD | 1.73 ± 0.11 | 1.49 ± 0.13 | 1.02 ± 0.17 | 0.96 ± 0.20 | 0.99 ± 0.17 | 1.05 ± 0.17 | |
BYF | 1.71 ± 0.12 | 1.47 ± 0.20 | 1.05 ± 0.20 | 1.11 ± 0.22 | 1.17 ± 0.28 | 1.24 ± 0.28 |